CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 62 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $73 | -36.0% | 49,959 | 0.0% | 0.01% | -36.4% |
Q2 2023 | $114 | +153.3% | 49,959 | 0.0% | 0.01% | +120.0% |
Q1 2023 | $45 | +7.1% | 49,959 | 0.0% | 0.01% | +25.0% |
Q4 2022 | $42 | -99.9% | 49,959 | 0.0% | 0.00% | -20.0% |
Q3 2022 | $41,000 | -16.3% | 49,959 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $49,000 | -40.2% | 49,959 | 0.0% | 0.01% | -28.6% |
Q1 2022 | $82,000 | +70.8% | 49,959 | +150.3% | 0.01% | +75.0% |
Q4 2021 | $48,000 | -50.5% | 19,959 | 0.0% | 0.00% | -60.0% |
Q3 2021 | $97,000 | +83.0% | 19,959 | 0.0% | 0.01% | +100.0% |
Q2 2021 | $53,000 | -13.1% | 19,959 | 0.0% | 0.01% | -16.7% |
Q1 2021 | $61,000 | -14.1% | 19,959 | 0.0% | 0.01% | -25.0% |
Q4 2020 | $71,000 | -11.2% | 19,959 | 0.0% | 0.01% | -20.0% |
Q3 2020 | $80,000 | -51.8% | 19,959 | -67.3% | 0.01% | -56.5% |
Q2 2020 | $166,000 | +28.7% | 60,959 | 0.0% | 0.02% | +27.8% |
Q1 2020 | $129,000 | -70.3% | 60,959 | -23.8% | 0.02% | -60.0% |
Q4 2019 | $435,000 | +11.3% | 80,000 | -38.5% | 0.04% | +7.1% |
Q3 2019 | $391,000 | -19.5% | 130,000 | 0.0% | 0.04% | -19.2% |
Q2 2019 | $486,000 | -7.1% | 130,000 | 0.0% | 0.05% | -5.5% |
Q1 2019 | $523,000 | +9.6% | 130,000 | 0.0% | 0.06% | +1.9% |
Q4 2018 | $477,000 | +73.5% | 130,000 | +305.1% | 0.05% | +92.9% |
Q3 2018 | $275,000 | – | 32,090 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 3,749,379 | $18,147,000 | 3.77% |
VR Adviser, LLC | 3,427,461 | $16,589,000 | 2.13% |
ADAMS STREET PARTNERS LLC | 3,275,616 | $15,854,000 | 2.04% |
Telemetry Investments, L.L.C. | 196,168 | $949,000 | 1.28% |
DC Investments Management, LLC | 50,709 | $245,000 | 0.46% |
Orbimed Advisors | 6,943,654 | $33,607,000 | 0.37% |
EcoR1 Capital, LLC | 2,081,077 | $10,072,000 | 0.35% |
BVF INC/IL | 1,370,947 | $6,635,000 | 0.26% |
Ikarian Capital, LLC | 757,545 | $3,666,000 | 0.26% |
CHI Advisors LLC | 165,927 | $803,000 | 0.23% |